| API LIST原料药产品列表 | |||||
No. | API Name原料药名称 | CAS NO. | Indication适应症 | Spec.规格 | Stage阶段 |
| 1 | Clindamycin Hydrochloride 盐酸克林霉素 | 21462-39-5 | Anti-infection 抗感染 | FDA /CP/ CEP/USP | Commercial 商业化 |
| 2 | Clindamycin Phosphate | 24729-96-2 | Anti-infection 抗感染 | FDA /CP/CEP/USP | Commercial 商业化 |
| 3 | Amphotericin B (Oral & Injection) 两性霉素 B（口服级&注射级） | 1397-89-3 | Antifungal | CP/EP/USP | Commercial 商业化 |
| 4 | Clindamycin Palmitate Hydrochloride 盐酸克林霉素棕榈酸酯 | 25507-04-4 | Anti-infection 抗感染 | CP/EP/USP | Commercial 商业化 |
| 5 | Agomelatine 阿戈美拉汀 | 138112-76-2 | Anti-depression 抗抑郁 | INH 企业标准 | Commercial 商业化 |
| 6 | Lactulose 乳果糖 | 4618-18-2 | Constipation 便秘 | INH 企业标准 | PV 验证 |
| 7 | Vortioxetine Hydrobromide 氢溴酸沃替西汀 | 960203-27-4 | Anti-depression 治疗重度抑郁症 | INH 企业标准 | PV 验证 |
| 8 | Netupitant 奈妥吡坦 | 290297-26-6 | Prevent Vomiting | INH 企业标准 | R&D 研发 |
| 9 | Fosnetupitant | 1703748-89-3 | Prevent Vomiting 化疗呕吐 | INH 企业标准 | R&D 研发 |
| 10 | Anidulafungin | 166663-25-8 | Antifungal 抗真菌 | INH 企业标准 | R&D 研发 |
| 11 | Caspofungin 卡泊芬净 | 162808-62-0 | Antifungal 抗真菌 | INH 企业标准 | R&D 研发 |
| 12 | Carboprost Tromethamine | 58551-69-2 | 终止妊娠 | INH 企业标准 | R&D 研发 |
注：专利期产品仅供研发使用Products under patent protection are for R&D only.
| Intermediate LIST中间体产品列表 | ||||
No. | Intermediate Name品名 | CAS No. | Structure结构式 | Usage用途 |
| 1 | 7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate 3,4-二氢-7-甲氧基-4-氧代喹唑啉-6-醇乙酸酯 | 179688-53-0 |  | Constructing core structure of EGFR inhibitors. EGFR抑制剂母核 |
| 2 | Methyl-d3-amine hydrochloride 氘代甲胺盐酸盐 | 7436-22-8 |  | Deuterated building block. 氘代砌块 |
| 3 | tert-Butyl (4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetate 瑞舒伐他汀钙D4中间体 | 154026-94-5 |  | Starting material of Rosuvastatin Calcium 瑞舒伐他汀钙片的起始物料 |
| 4 | tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate 瑞舒伐他汀钙D5中间体 | 154026-95-6 |  | |
| 5 | (R)-(+)-1-Boc-3-aminopyrrolidine (R)-(+)-1-Boc-3-氨基吡咯烷 | 147081-49-0 |  | Chiro building Block. For Ceftobiprole, Sunvozertinib, etc. 手性砌块 |
| 6 | tert-butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate 4 - (6 -氨基吡啶- 3 -基)哌啶- 1 -甲酸叔丁酯 | 1198408-35-3 |  | Building Block. 合成砌块 |
| 7 | Vortioxetine 伏硫西汀 | 508233-74-7 |  | Intermediate of Vortioxetine 伏硫西汀中间体 |
| 8 | Vortioxetine Hydrochloric 伏硫西汀盐酸盐 | 960203-28-5 |  | |
| 9 | Di-tert-butyl Chloromethyl Phosphate | 229625-50-7 |  | Intermediate of Fosnetupitant 福奈妥匹坦中间体 |
| 10 | N-tert-butyl-6-chloro-4-(o-tolyl)nicotinamide N-叔丁基-6-氯-4-邻甲苯基烟酰胺 | 342417-04-3 |  | Intermediate of Netupitant and Fosnetupitant 奈妥匹坦中间体 |
| 11 | Methyl-[6-(4-methyl-piperazin-1-yl)-4-o-tolyl-pyridin-3-yl]-amine N-甲基-4-(2-甲基苯基)-6-(4-甲基-1-哌嗪基)-3-吡啶 胺 | 290297-25-5 |  | |
| 12 | (S)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic acid (S)-2-三氟甲基-2-羟基丙酸 | 24435-45-8 |  | Building Block 合成砌块 |
| 13 | (R)- 3,3,3-Trifluoro-2-hydroxy-2-methylpropionic acid (R)-2-三氟甲基-2-羟基丙酸 | 44864-47-3 |  | |
| 14 | (4-(2-(dimethylamino)ethoxy)phenyl)(4-hydroxyphenyl)methanone [4- [2-（二甲氨基氨基）乙氧基]苯基](4-羟苯基)甲酮 | 173163-13-8 |  | Building Block 合成砌块 |
| 15 | (S)-2-(diphenylmethyl)pyrrolidine (2S)-2-(二苯基甲基)吡咯烷 | 119237-64-8 |  | Chiral catalyst 手性催化剂 |
| 16 | (R)-2-(diphenylmethyl)pyrrolidine (2R)-2-(二苯基甲基)吡咯烷 | 22348-31-8 |  | |
注：专利期产品仅供研发使用Products under patent protection are for R&D only.
Cosmetic & Health Product Efficacious Ingredients美妆和保健品功效成分 | |||||
| No. | Name品名 | CAS No. | Efficacy适应症 | Spec. 规格 | Stage阶段 |
| 1 | Ectoin 依克多因 | 96702-03-3 | Hydrate and Encase moisture | INH 企业标准 | Commercial商业化 |
| 2 | NRH 还原型烟酰胺核糖 | 19132-12-8 | Anti-aging | INH 企业标准 | R&D 研发 |
| 3 | N-Acetyl-L-Carnosine N-乙酰基肌肽 | 56353-15-2/56353-23-0 | Anti-Oxidant and Anti-Glycation | INH 企业标准 | R&D 研发 |
注：专利期产品仅供研发使用Products under patent protection are for R&D only.
